EdgarLookup

EPR PROPERTIES — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that EPR PROPERTIES filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
38.3%
Profit Margin
Net income ÷ revenue
4.8%
Return on Assets
Net income ÷ assets
1.63x
Debt-to-Equity
Total liabilities ÷ equity
+2.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $718.36M Feb 26, 2026
FY2025 Dec 31, 2024 $698.07M Feb 26, 2026
FY2025 Dec 31, 2023 $705.67M Feb 26, 2026
FY2024 Dec 31, 2022 $658.03M Feb 27, 2025
FY2023 Dec 31, 2021 $531.68M Feb 29, 2024
FY2020 Dec 31, 2020 $93.41M Feb 25, 2021
FY2020 Sep 30, 2020 $63.88M Feb 25, 2021
FY2020 Jun 30, 2020 $106.36M Feb 25, 2021
FY2020 Mar 31, 2020 $151.01M Feb 25, 2021
FY2020 Dec 31, 2019 $170.35M Feb 25, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $274.94M Feb 26, 2026
FY2025 Dec 31, 2024 $146.07M Feb 26, 2026
FY2025 Dec 31, 2023 $173.05M Feb 26, 2026
FY2024 Dec 31, 2022 $176.23M Feb 27, 2025
FY2023 Dec 31, 2021 $98.61M Feb 29, 2024
FY2020 Dec 31, 2020 ($19.98M) Feb 25, 2021
FY2020 Sep 30, 2020 ($85.90M) Feb 25, 2021
FY2020 Jun 30, 2020 ($62.97M) Feb 25, 2021
FY2020 Mar 31, 2020 $37.12M Feb 25, 2021
FY2020 Dec 31, 2019 $36.30M Feb 25, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $414.30M Feb 26, 2026
FY2025 Dec 31, 2024 $315.67M Feb 26, 2026
FY2025 Dec 31, 2023 $306.40M Feb 26, 2026
FY2024 Dec 31, 2022 $310.96M Feb 27, 2025
FY2023 Dec 31, 2021 $278.81M Feb 29, 2024
FY2022 Dec 31, 2020 $52.13M Feb 23, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $420.95M Feb 26, 2026
FY2025 Dec 31, 2024 $393.14M Feb 26, 2026
FY2025 Dec 31, 2023 $447.09M Feb 26, 2026
FY2024 Dec 31, 2022 $441.72M Feb 27, 2025
FY2023 Dec 31, 2021 $306.93M Feb 29, 2024
FY2022 Dec 31, 2020 $65.27M Feb 23, 2023
FY2021 Dec 31, 2019 $439.53M Feb 23, 2022
FY2020 Dec 31, 2018 $484.33M Feb 25, 2021
FY2019 Dec 31, 2017 $398.27M Feb 25, 2020
FY2018 Dec 31, 2016 $305.36M Feb 28, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $263.92M Feb 27, 2025
FY2024 Dec 31, 2023 $269.43M Feb 27, 2025
FY2023 Dec 31, 2022 $402.52M Feb 29, 2024
FY2018 Apr 6, 2017 $61.20M Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.70B Feb 26, 2026
FY2025 Dec 31, 2024 $5.62B Feb 26, 2026
FY2024 Dec 31, 2023 $5.70B Feb 27, 2025
FY2023 Dec 31, 2022 $5.76B Feb 29, 2024
FY2022 Dec 31, 2021 $5.80B Feb 23, 2023
FY2021 Dec 31, 2020 $6.70B Feb 23, 2022
FY2020 Dec 31, 2019 $6.58B Feb 25, 2021
FY2019 Dec 31, 2018 $6.13B Feb 25, 2020
FY2018 Dec 31, 2017 $6.19B Feb 28, 2019
FY2017 Dec 31, 2016 $4.87B Mar 1, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.37B Feb 26, 2026
FY2025 Dec 31, 2024 $3.29B Feb 26, 2026
FY2024 Dec 31, 2023 $3.25B Feb 27, 2025
FY2023 Dec 31, 2022 $3.22B Feb 29, 2024
FY2022 Dec 31, 2021 $3.18B Feb 23, 2023
FY2021 Dec 31, 2020 $4.07B Feb 23, 2022
FY2020 Dec 31, 2019 $3.57B Feb 25, 2021
FY2019 Dec 31, 2018 $3.27B Feb 25, 2020
FY2018 Dec 31, 2017 $3.26B Feb 28, 2019
FY2017 Dec 31, 2016 $2.68B Mar 1, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2015 $2.07B Feb 25, 2016
FY2015 Dec 31, 2014 $1.93B Feb 25, 2016
FY2014 Dec 31, 2013 $1.69B Feb 25, 2015
FY2013 Dec 31, 2012 $1.46B Feb 28, 2014
FY2012 Dec 31, 2011 $1.47B Feb 27, 2013
FY2011 Dec 31, 2010 $1.60B Feb 24, 2012
FY2010 Dec 31, 2009 $1.47B Mar 1, 2011

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $693.0K Feb 26, 2026
FY2025 Dec 31, 2024 $693.0K Feb 26, 2026
FY2024 Dec 31, 2023 $693.0K Feb 27, 2025
FY2023 Dec 31, 2022 $693.0K Feb 29, 2024
FY2022 Dec 31, 2021 $693.0K Feb 23, 2023
FY2021 Dec 31, 2020 $693.0K Feb 23, 2022
FY2020 Dec 31, 2019 $693.0K Feb 25, 2021
FY2019 Dec 31, 2018 $693.0K Feb 25, 2020
FY2018 Dec 31, 2017 $693.0K Feb 28, 2019
FY2017 Dec 31, 2016 $693.0K Mar 1, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $90.58M Feb 26, 2026
FY2025 Dec 31, 2024 $22.06M Feb 26, 2026
FY2025 Dec 31, 2023 $78.08M Feb 26, 2026
FY2025 Dec 31, 2022 $107.93M Feb 26, 2026
FY2024 Dec 31, 2021 $288.82M Feb 27, 2025
FY2023 Dec 31, 2020 $1.03B Feb 29, 2024
FY2022 Dec 31, 2019 $528.76M Feb 23, 2023
FY2021 Dec 31, 2018 $5.87M Feb 23, 2022
FY2020 Dec 31, 2017 $41.92M Feb 25, 2021
FY2019 Dec 31, 2016 $19.34M Feb 25, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.93B Feb 26, 2026
FY2025 Dec 31, 2024 $2.86B Feb 26, 2026
FY2024 Dec 31, 2023 $2.82B Feb 27, 2025
FY2023 Dec 31, 2022 $2.81B Feb 29, 2024
FY2022 Dec 31, 2021 $2.80B Feb 23, 2023
FY2021 Dec 31, 2020 $3.69B Feb 23, 2022
FY2020 Dec 31, 2019 $3.10B Feb 25, 2021
FY2019 Dec 31, 2018 $2.99B Feb 25, 2020
FY2018 Dec 31, 2017 $3.03B Feb 28, 2019
FY2017 Dec 31, 2016 $2.49B Mar 1, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 26, 2026
FY2025 Dec 31, 2024 1 Feb 26, 2026
FY2025 Dec 31, 2023 1 Feb 26, 2026
FY2024 Dec 31, 2022 2 Feb 27, 2025
FY2023 Dec 31, 2021 1 Feb 29, 2024
FY2020 Dec 31, 2020 0 Feb 25, 2021
FY2020 Sep 30, 2020 (1) Feb 25, 2021
FY2020 Jun 30, 2020 0 Feb 25, 2021
FY2020 Mar 31, 2020 0 Feb 25, 2021
FY2020 Dec 31, 2019 0 Feb 25, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 26, 2026
FY2025 Dec 31, 2024 1 Feb 26, 2026
FY2025 Dec 31, 2023 1 Feb 26, 2026
FY2024 Dec 31, 2022 2 Feb 27, 2025
FY2023 Dec 31, 2021 1 Feb 29, 2024
FY2020 Dec 31, 2020 0 Feb 25, 2021
FY2020 Sep 30, 2020 (1) Feb 25, 2021
FY2020 Jun 30, 2020 0 Feb 25, 2021
FY2020 Mar 31, 2020 0 Feb 25, 2021
FY2020 Dec 31, 2019 0 Feb 25, 2021